Published in J Pharmacol Exp Ther on November 01, 1990
Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol (1992) 1.16
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol (1995) 0.93
Pathway-specific effects of calcitonin gene-related peptide on irideal arterioles of the rat. J Physiol (1997) 0.92
Mechanism of the vasodilator action of calcitonin gene-related peptide in conscious rats. Br J Pharmacol (1992) 0.90
Rapid nitric oxide- and prostaglandin-dependent release of calcitonin gene-related peptide (CGRP) triggered by endotoxin in rat mesenteric arterial bed. Br J Pharmacol (1996) 0.86
Inhibition of hypoxia-induced relaxation of rabbit isolated coronary arteries by NG-monomethyl-L-arginine but not glibenclamide. Br J Pharmacol (1994) 0.84
Cross talk between receptors mediating contraction and relaxation in the arterioles but not the dilator muscle of the rat iris. Br J Pharmacol (1995) 0.84
Role of calcitonin gene-related peptide in bone repair after cyclic fatigue loading. PLoS One (2011) 0.82
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases. Biomed Res Int (2016) 0.75
Local regulation of adrenergic neurotransmission. Physiol Rev (1977) 2.63
Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8-37) and CGRP receptor desensitization. Biochem Biophys Res Commun (1990) 1.27
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol (1987) 1.26
Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A (2000) 1.21
Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res (1976) 1.13
The mechanism of action of nicotine on adrenergic neurons in the perfused guinea-pig heart. J Pharmacol Exp Ther (1972) 1.10
Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol (1998) 1.03
The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.02
Enhancement of the electrically induced release of norepinephrine from the rat portal vein: mediation by beta 2-adrenoceptors. Eur J Pharmacol (1979) 0.98
Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiovasc Pharmacol (1987) 0.98
Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain. Eur J Pharmacol (1981) 0.98
Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia. Life Sci (1982) 0.98
Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. Am J Physiol (1997) 0.98
Neuronal and non-neuronal modulation of sympathetic neurovascular transmission. Acta Physiol (Oxf) (2011) 0.97
Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion. Eur J Pharmacol (1967) 0.97
Effects of endothelin on regional hemodynamics in conscious rats. Eur J Pharmacol (1989) 0.96
Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J Pharmacol Exp Ther (1992) 0.95
Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Annu Rev Pharmacol Toxicol (1985) 0.92
Blood pressure increases after injection of neuropeptide Y into posterior hypothalamic nucleus. Am J Physiol (1988) 0.92
Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Pharmacol (1982) 0.91
Molecular aspects of Huntington's disease. J Neurosci Res (1998) 0.90
Influence of adrenalectomy on the synthesis of norepinephrine in the rat heart. J Pharmacol Exp Ther (1969) 0.89
Neuroeffector mechanisms. Annu Rev Physiol (1980) 0.89
Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen Pharmacol (1983) 0.89
Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain. Mol Pharmacol (1982) 0.88
A new perspective on the inhibitory role of nitric oxide in sympathetic neurotransmission. Biochem Biophys Res Commun (1995) 0.88
Maternal diabetes-induced hyperglycemia and acute intracerebral hyperinsulinism suppress fetal brain neuropeptide Y concentrations. Endocrinology (1997) 0.87
A student exercise in clinical pharmacology: Renal effects of diuretics. Curr Ther Res Clin Exp (1970) 0.87
Action of a beta adrenergic receptor blocking agent on the positive chronotropic response and uptake of norepinephrine in the perfused guinea-pig heart. J Pharmacol Exp Ther (1968) 0.85
Accumulation of norepinephrine in rat tissue following treatment with three beta-adrenergic antagonists. Arch Int Pharmacodyn Ther (1967) 0.84
Catecholamine uptake, accumulation, and release in acute porphyria. J Clin Invest (1977) 0.84
Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology (1974) 0.84
Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro. J Pharmacol Exp Ther (1986) 0.84
Integrated concentrations of catecholamines in phaeochromocytoma. Lancet (1977) 0.83
Role of neuropeptide Y in cold stress-induced hypertension. Peptides (1998) 0.83
Angiotensin facilitation of noradrenergic neurotransmission in central tissues of the rat: effects of sodium restriction. J Cardiovasc Pharmacol (1985) 0.83
Effect of prolactin on dopamine synthesis in medial basal hypothalamus: evidence for a short loop feedback. Brain Res (1979) 0.83
The effect of cyclic nucleotides on the release of 3H-dopamine from rat striatal slices. J Pharmacol Exp Ther (1976) 0.83
Evidence that noradrenergic transmitter release is regulated by presynaptic receptors. Fed Proc (1984) 0.82
Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC-12 cells. Am J Physiol (1994) 0.82
Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Blood Vessels (1987) 0.82
Effect of adenosine on adrenergic neurotransmission in the superfused rat portal vein. Blood Vessels (1979) 0.81
Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y. J Cardiovasc Pharmacol (1988) 0.81
Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse (1988) 0.81
Mechanism of pressor response to posterior hypothalamic injection of neuropeptide Y. Am J Physiol (1989) 0.81
Stimulation of rat liver phenylalanine hydroxylase activity by derivatives of vitamin E. Biochem Biophys Res Commun (1972) 0.81
Effect of muscarinic agonists on the release of (3H)noradrenaline from the guinea-pig perfused heart. J Pharm Pharmacol (1974) 0.81
Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats. Am J Physiol (1990) 0.80
Regional hemodynamic and baroreflex effects of endothelin in rats. Am J Physiol (1989) 0.80
Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein. Neurosci Lett (1991) 0.79
Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels. J Pharmacol Exp Ther (2005) 0.79
Presynaptic peptide receptors and hypertension. Ann N Y Acad Sci (1990) 0.79
Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells. Endocrinology (1994) 0.79
Angiotensin facilitation of 3H-norepinephrine release in central tissue of spontaneously hypertensive rats but not in Wistar-Kyoto rats: effects of sodium depletion. J Cardiovasc Pharmacol (1986) 0.79
Elevated neuropeptide Y gene expression and release during hypoglycemic stress. Peptides (1997) 0.79
Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices. Neurosci Lett (1982) 0.79
Cardiac and vascular actions of sarafotoxin S6b and endothelin-1. Life Sci (1990) 0.79
Neuropeptide Y inhibits depolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells. Eur J Pharmacol (1995) 0.78
Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat. J Pharmacol Exp Ther (1983) 0.78
Effect of low sodium diet on the facilitatory effect of angiotensin on 3H-norepinephrine release in the rat portal vein. Blood Vessels (1985) 0.78
Alterations in prejunctional adrenoceptor function in guinea pig and rat vas deferens after chronic ganglionic blockade. J Pharmacol Exp Ther (1981) 0.78
In vitro effects of neuropeptide Y at the vascular neuroeffector junction. Ann N Y Acad Sci (1990) 0.78
Noradrenergic transmission in the isolated portal vein of the spontaneously hypertensive rat. Hypertension (1984) 0.78
Effects of acetylcholine and atropine on the release of 14C-acetylcholine formed from U-14C-glucose in rat brain cortical and striatal prisms. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.78
Effect of muscarinic agonists on the release of 3H-norepinephrine and 3H-dopamine by potassium and electrical stimulation from rat brain slices. Life Sci (1974) 0.78
Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells. Regul Pept (1998) 0.78
Endothelin and sarafotoxin S6b have similar vasoconstrictor effects and postsynaptically mediated mechanisms. Eur J Pharmacol (1990) 0.77
Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells. Am J Physiol (1998) 0.77
Hemodynamic effects of posterior hypothalamic injection of neuropeptide Y in awake rats. Am J Physiol (1991) 0.77
Further evidence for an opioid receptor complex. J Neurobiol (1983) 0.77
Effects of social isolation on brain catecholamines and forced swimming in rats: prevention by antidepressant treatment. J Psychiatr Res (1990) 0.77
Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats. Am J Physiol (1995) 0.77
Regulation of nicotine-evoked dopamine release from PC12 cells. Life Sci (1991) 0.77
Pharmacological characterization of the release of neuropeptide Y-like immunoreactivity from the rat hypothalamus. Neuropharmacology (1993) 0.77
A novel mechanism prevents the development of hypertension during chronic cold stress. Auton Autacoid Pharmacol (2005) 0.77
The nicotinic-induced release of endogenous dopamine from rat striatal slices from animals chronically exposed to dimethylphenylpiperazinium (DMPP). Neurosci Lett (1986) 0.77
Comparison of norepinephrine release in hypertensive rats: II. Caudal artery and portal vein. Clin Exp Hypertens A (1986) 0.77
The release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats. Circ Res (1982) 0.77
Influence of aging on catecholamine levels, accumulation, and release in F-344 rats. Neurobiol Aging (1987) 0.77
Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases. J Neurochem (1996) 0.76
Effect of sodium depletion on the release of [3H]norepinephrine from central and peripheral tissue of Wistar-Kyoto and spontaneously hypertensive rats. J Cardiovasc Pharmacol (1985) 0.76
Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. Br J Clin Pharmacol (1990) 0.76
Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo. Brain Res (2001) 0.76
Comparison of norepinephrine release in hypertensive rats: I. Hypothalamic and brainstem tissues. Clin Exp Hypertens A (1986) 0.76
Prostanoid-induced modulation of neuropeptide Y and noradrenaline release from the rat mesenteric bed. Auton Autacoid Pharmacol (2003) 0.76
Alterations in the field stimulation-induced release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol (1987) 0.76
A comparison of the hemodynamic effects of endothelin-1 and sarafotoxin S6b in conscious rats. J Pharmacol Exp Ther (1991) 0.76
Cerebral monoamines and lidocaine toxicity in rats. Anesthesiology (1982) 0.76
Characterization of the depressor effect of intrathecal endothelin in anesthetized rats. Am J Physiol (1991) 0.76
Modulation of terminal excitability of mesolimbic dopaminergic neurons by D-amphetamine and haloperidol. Brain Res (1985) 0.76
The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors. Eur J Pharmacol (1983) 0.76
Neuropeptide Y gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regul Pept (1998) 0.76